Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2010 | 12-2009 | 09-2009 | 07-2009 | 06-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 446,200 | 558,500 | 535,500 | 511,600 | N/A |
| Marketable Securities | 111,300 | 51,000 | N/A | N/A | N/A |
| Receivables | 210,500 | 186,500 | 197,600 | 194,700 | N/A |
| Inventories | 122,800 | 123,900 | 124,600 | 140,000 | N/A |
| Other current assets | 0 | 0 | 9,800 | 0 | 0 |
| TOTAL | $929,600 | $950,000 | $900,800 | $879,300 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 153,800 | 158,300 | 162,800 | 166,900 | N/A |
| Investments And Advances | 79,200 | 0 | 0 | 76,000 | 0 |
| Intangibles | 89,800 | 94,600 | 93,500 | 94,900 | 0 |
| Other Non-Current Assets | 92,700 | 133,200 | 186,500 | 105,600 | 0 |
| TOTAL | $415,500 | $386,100 | $442,800 | $443,400 | $N/A |
| Total Assets | $1,345,100 | $1,336,100 | $1,343,600 | $1,322,700 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 300 | 600 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 77,300 | 73,600 | 83,000 | 77,800 | 0 |
| Accrued Expenses | 92,000 | 82,100 | 80,300 | 70,700 | N/A |
| TOTAL | $251,900 | $230,700 | $236,100 | $210,800 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 650,900 | 650,900 | 651,000 | 651,000 | N/A |
| Other Non-Current Liabilities | 86,600 | 95,200 | 95,700 | 81,500 | -100 |
| TOTAL | $737,900 | $746,300 | $746,600 | $732,500 | $N/A |
| Total Liabilities | $989,800 | $977,000 | $982,700 | $943,300 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 96,989 | 96,971 | 96,626 | 96,626 | N/A |
| Common Shares | N/A | N/A | 23,600 | N/A | N/A |
| Retained earnings | N/A | N/A | -965,900 | N/A | N/A |
| Other shareholders' equity | 355,300 | 359,100 | -8,700 | 379,400 | 0 |
| TOTAL | $355,300 | $359,100 | $360,900 | $379,400 | $N/A |
| Total Liabilities And Equity | $1,345,100 | $1,336,100 | $1,343,600 | $1,322,700 | $0 |